PERSISTENCE RATE WITH SUBCUTANEOUS BIOLOGIC THERAPIES IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA)

被引：0
|
作者：
Lyu, R. [1 ]
Ding, Q. [2 ]
Govoni, M. [3 ]
Fan, T. [1 ]
机构：
[1] Merck & Co Inc, Whitehouse Stn, NJ USA
[2] Temple Univ, Philadelphia, PA 19122 USA
[3] Merck Sharp & Dohme Ltd, Rome, Italy
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS64
引用
收藏
页码：A384 / A384
页数：1
相关论文
共 50 条
  • [1] TREATMENT PERSISTENCE WITH SUBCUTANEOUS BIOLOGIC THERAPIES IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Lyu, R.
    Govoni, M.
    Ding, Q.
    Fan, T.
    Ogbonnaya, A.
    Donga, P.
    Korn, J.
    Makin, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1162 - 1163
  • [2] PERSISTENCE RATE WITH SUBCUTANEOUS BIOLOGIC THERAPIES IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS)
    Lyu, R.
    Ding, Q.
    Govoni, M.
    Makin, C.
    Korn, J.
    Fan, T.
    Ogbonnaya, A.
    Black, C. M.
    Kachroo, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1151 - 1151
  • [3] PERSISTENCE RATE WITH SUBCUTANEOUS BIOLOGIC THERAPIES IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS)
    Govoni, M.
    Lyu, R.
    Ding, Q.
    Fan, T.
    VALUE IN HEALTH, 2014, 17 (07) : A384 - A384
  • [4] TREATMENT PERSISTENCE WITH SUBCUTANEOUS BIOLOGIC THERAPIES IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA)
    Lyu, R.
    Ding, Q.
    Govoni, M.
    Fan, T.
    VALUE IN HEALTH, 2014, 17 (07) : A384 - A385
  • [5] TREATMENT PERSISTENCE WITH SUBCUTANEOUS BIOLOGIC THERAPIES IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA)
    Lyu, R.
    Ding, Q.
    Govoni, M.
    Makin, C.
    Korn, J.
    Fan, T.
    Ogbonnaya, A.
    Black, C. M.
    Kachroo, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 357 - 357
  • [6] Comparing biologic persistence and healthcare costs in rheumatoid arthritis patients initiating subcutaneous biologics
    Nadkarni, Anagha
    McMorrow, Donna
    Fowler, Robert
    Smith, David
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2017, 6 (08) : 659 - 669
  • [7] The Persistence of Biologic Therapies for Psoriatic Arthritis
    Jasmen, Magdalena
    Garcia, Dominga
    Ibanez, Sebastian
    Diaz, Pamela
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2025, 31 (03) : 107 - 116
  • [8] Applying biologic therapies to the management of patients with rheumatoid arthritis
    Epstein, Alan A.
    Kremer, Joel M.
    Siegel, Evan
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2014, 43 (04) : 577 - 577
  • [9] TREATMENT PATTERNS AND PERSISTENCE WITH SUBCUTANEOUS BIOLOGIC THERAPIES IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Govoni, M.
    Lyu, R.
    Ding, Q.
    Fan, T.
    Ogbonnaya, A.
    Donga, P.
    Korn, J.
    Makin, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1157 - 1157
  • [10] Assessing intangibles in biologic therapies for rheumatoid arthritis (RA). A willingness to pay (WTP) study in Spanish patients
    Badia, X
    Serrano, D
    Magaz, S
    VALUE IN HEALTH, 2004, 7 (06) : 669 - 669
12345